Contrast-enhanced fluid-attentuated inversion recovery (FLAIR) magnetic res
onance (MR) imaging has shown to be a valuable diagnostic modality in the a
ssessment of cerebral gliomas. In this study we report of a potential pitfa
ll regarding the delineation of enhancing tumor parts on contrast enhanced
FLAIR imaging. In a limited number of patients, the administration of gadol
inium obscures the area of contrast enhancement on contrast enhanced FLAIR
images. Therefore the delineation of the macroscopic tumor parts, which are
of great importance for the treatment planning is substantially worsened.
(C) 2000 Elsevier Science Inc. All rights reserved.